Skip to main content
Prof. Dr. Christian Bode
Prof. Dr. Christian Bode
UKB Media Team

News categories: Focus

Welcoming Christian Bode to ImmunoSensation

We are delighted to welcome Prof. Dr. Christian Bode from the Department of Anesthesiology and Intensive Care Medicine at the University Hospital Bonn to the Cluster of Excellence ImmunoSensation2. Christian Bode is a physician-scientist whose work focuses on the intersection of immunology and critical care. His research centers around understanding the immune responses in patients undergoing major surgery, acute lung failure (ARDS), or sepsis.

Research focus: Investigating immune responses in critical care

Christian Bode’s research explores the immune alterations triggered by severe physical stressors such as surgical trauma, sepsis, and acute organ failure. He has a special interest in deciphering the role of innate immune mechanisms and the dysregulated inflammatory responses that frequently complicate recovery in critically ill patients. By leveraging innovative approaches, including biomarker profiling and immunomodulatory interventions, his work seeks to explore the intricate balance between protective immunity and harmful hyperinflammation.

His expertise in studying the immune-metabolic dynamics during critical illness offers a promising avenue for identifying novel therapeutic targets. Christian Bode's recent investigations include the role of danger-associated molecular patterns (DAMPs) and their contribution to systemic inflammation and tissue injury in systemic inflammatory response syndrome (SIRS) and ARDS. These findings could inform the development of personalized therapies that improve outcomes for patients in intensive care units.

Collaborations within the Cluster

Christian Bode’s research aligns closely with the objectives of the ImmunoSensation2 Cluster, particularly in areas related to inflammation, innate immunity, and tissue damage. Through collaborations with immunologists, molecular biologists, and clinical researchers within the Cluster, Christian Bode aims to integrate advanced immunological technologies to further his investigations. Potential cooperations include the use of advanced multi-omics approaches to dissect immune heterogeneity in patients with SIRS and ARDS as well as exploring translational models for immunotherapy in intensive care medicine.

Looking ahead

In the future, Christian Bode envisions utilizing the collaborative environment of ImmunoSensation2 to deepen our understanding of immune dysregulation in critical care. His long-term goal is to translate mechanistic insights into targeted therapeutic strategies that can mitigate immune-related complications and promote recovery.

"Joining ImmunoSensation2 offers an exceptional opportunity to deepen our understanding of immune responses in critically ill patients," says Christian Bode. "I look forward to collaborating with experts across disciplines to develop innovative solutions that improve outcomes in intensive care medicine."

We are excited to have Christian Bode join the Cluster and look forward to the impactful contributions his research will bring to ImmunoSensation2.

 

Contact:

Prof. Dr. Christian Bode

Department of Anesthesiology and Intensive Care Medicine

University Hospital Bonn

Email: christian.bode@ukbonn.de

Related news

Gunther Hartmann and Christina Wuebben

News categories: Focus

An RNA key against viruses

Activating the body's antiviral defense system: A novel RIG-I ligand developed at the Medical Faculty of the University of Bonn and the University Hospital Bonn (UKB) helps the body to recognize and fight off certain viruses at an early stage. This molecular structure has potential for the prevention and treatment of viral infections. Based on the research results, there are now plans to develop and market an antiviral nasal spray to protect against viral respiratory infections.
View entry
members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program

News categories: Focus

Joining forces against future pandemics

Three days of scientific exchange, workshops, and new impulses: Until July 2, 2025, members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program are gathered at University Hospital Bonn (UKB) for a symposium to reflect on the current state of their research and discuss further steps. The joint program of the Cumming Global Centre for Pandemic Therapeutics at the University of Melbourne and of the University of Bonn aims to combat future pandemics with novel therapeutics.
View entry
Prof. Dr. Jörg Wenzel

News categories: Focus

Welcoming Jörg Wenzel to ImmunoSensation

We are delighted to welcome Prof. Dr. Jörg Wenzel from the Center for Skin Diseases at the University Hospital Bonn to the Cluster of Excellence ImmunoSensation2. Jörg Wenzel is a dermatologist and physician-scientist with extensive expertise in inflammatory skin diseases and cutaneous immunology.
View entry

Back to the news overview